Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FluoGuide ASOSTO:FLUO 31 Market Cap is kr508.46 Mil as of Aug. 09, 2026. GuruFocus rates OSTO:FLUO with a GF Score™ of 31/100. The stock has 4 warning signs investors should review. Among 1,420 Biotechnology companies, FluoGuide AS ranks worse than 62.11% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). FluoGuide AS's share price for the quarter that ended in Mar. 2026 was kr36. FluoGuide AS's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 16.35 Mil. Therefore, FluoGuide AS's market cap for the quarter that ended in Mar. 2026 was kr588.56 Mil.
FluoGuide AS's quarterly market cap
increased
from Sep. 2025 (kr533.90 Mil) to Dec. 2025 (kr560.77 Mil) and
increased
from Dec. 2025 (kr560.77 Mil) to Mar. 2026 (kr588.56 Mil).
FluoGuide AS's annual market cap
declined
from Dec. 2023 (kr747.13 Mil) to Dec. 2024 (kr533.22 Mil) but then
increased
from Dec. 2024 (kr533.22 Mil) to Dec. 2025 (kr560.77 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. FluoGuide AS's Enterprise Value for Today is kr456.66 Mil.
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
FluoGuide AS Market Cap Related Terms
FluoGuide AS Market Cap Historical Data
* Premium members only.
The historical data trend for FluoGuide AS's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:FLUO vs VRTX, REGN, RVMD: Market Cap Comparison
For the Biotechnology subindustry, FluoGuide AS's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
FluoGuide AS Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, FluoGuide AS's Market Cap distribution charts can be found below:
* The bar in red indicates where FluoGuide AS's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
FluoGuide AS's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FluoGuide AS (OSTO:FLUO) has a Market Cap of kr508.46 Mil as of Aug. 09, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on FluoGuide AS and its competitors. According to the industry distribution chart, FluoGuide AS ranks #882 out of 1420 companies in the Biotechnology industry, placing it in the top 62.1%.
Is FluoGuide AS's Market Cap too high?
FluoGuide AS's current Market Cap is kr508.46 Mil. Based on the distribution chart, FluoGuide AS ranks #882 out of 1420 companies in the Biotechnology industry, which is below the industry midpoint. Overall, FluoGuide AS has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does FluoGuide AS's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, FluoGuide AS ranks #882 out of 1420 companies for Market Cap. This places FluoGuide AS in the lower half of its industry. The industry median Market Cap is 116.96. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 116.96, based on 1,420 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on FluoGuide AS and its competitors. For the Biotechnology industry, the median Market Cap is 116.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. FluoGuide AS's current Market Cap is kr508.46 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is FluoGuide AS stock overvalued right now?
FluoGuide AS (OSTO:FLUO) has a current Market Cap of kr508.46 Mil. The current Market Cap is kr508.46 Mil. FluoGuide AS's overall GF Score™ is 31/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For FluoGuide AS (OSTO:FLUO), the current Market Cap is kr508.46 Mil as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
FluoGuide AS is a clinical-stage biotechnology company focused on developing drugs that maximize surgical outcomes by making cancer fluorescent. Its technology includes uPAR, which is part of a proteolytic system, and FG001, a product injected into the patient's vein prior to surgery.
31GF Score
Get the complete analysis for OSTO:FLUO
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:FLUO has been successfully added to your 
